ECP 2018 Final Programme

Monday, 10 Sept 38 ECP 2018 · Bilbao Scientific Programme a Monday e Monday, 10 September 2018 SY-12 Symposium 08:30–12:00 Auditorium Joint Symposium Gynaecological Pathology & ESGO Cervical cancer clinical practice guidelines (ESGO-ESTRO-ESP) Chairs: Maria Rosaria Raspollini, Italy David Cibula, Czech Republic 001 08:30–08:44 Development of new guidelines David Cibula, Czech Republic 002 08:44–09:07 Specimen grossing and sampling Maria Rosaria Raspollini, Italy 003 09:07–09:30 The pathological analysis of lymph node Sigurd Lax, Austria 004 10:30–11:10 The cervical cancer pathology report: detailed description of what is needed for patient management Glenn McCluggage, United Kingdom 005 11:10–11:35 Management of early stages: algorithms focusing on the histological data David Cibula, Czech Republic 006 11:35–12:00 Management of late stages: algorithms focusing on the histological data Mary McCormack, United Kingdom OFP-04 Oral Free Paper Session 08:30–12:00 Room A1 Digestive Diseases Pathology – GI Chairs: Miriam Cuatrecasas, Spain Jean-François Fléjou, France 001 08:30–08:40 The consensus molecular subtypes (CMS) and tumour budding: a study on 1525 patients Inti Zlobec, Switzerland A. Trinh, C. Lädrach, H. Dawson, S. ten Hoorn, P. J. K. Kuppen, M. S. Reimers, M. Koopman, C. J. A. Punt, A. Lugli, L. Vermeulen 002 08:40–08:50 Assessing the stability of pathologist diagnostic rate over seven years in a cohort of 38,813 colorectal polyp specimens and implications for histomorphology and statistical process control/next generation quality Michael Bonert, Canada A. Naqvi, M. Rahman, H. Kazerouni, P. Major 003 08:50–09:00 Does tumour budding contribute to the molecular classification of colorectal carcinoma? Maria Carolina Martinez Ciarpaglini, Spain S. Oltra Sanchiz, F. Carrasco Bailén, N. Tarazona, C. Mongort, S. Rosello, D. Roda, A. Cervantes, S. Navarro 004 09:00–09:10 Tumour budding versus T-cell infiltrates in colorectal cancer: can opposite forces be united? Heather Dawson, Switzerland M. Eichmann, L. Christe, I. Zlobec, A. Lugli 005 09:10–09:20 Profiling lymphocyte and macrophage infiltration in association with tumour budding to personalise stage II colorectal cancer prognosis Ines P. Nearchou, United Kingdom C. G. Gavriel, D. J. Harrison, P. D. Caie 006 09:20–09:30 Morphological assessment of immune checkpoint expression in colorectal adenocarcinoma Axelle Canard, France A. Scriva, K. Wanherdrick, M. Svrcek, J.-F. Fléjou, A. Duval, P. Cervera 007 10:30–10:40 E-learning for determining the tumour- stroma ratio (TSR) as addition in routine diagnostic pathology; the UNITED study Marloes Smit, The Netherlands G. van Pelt, A. Farina Sarasqueta, V. Terpstra, J.-F. Fléjou, R. Tollenaar, H. van Krieken, W. E. Mesker 009 10:50–11:00 MicroRNAs as markers of epithelial-mesen- chymal transition in colorectal cancerogenesis Branislava Rankovic, Slovenia E. Boštjanèiè, M. Žlajpah, N. Zidar